medigraphic.com
Instituto Nacional de Salud Pública

2022, Number 1

<< Back Next >>

salud publica mex 2022; 64 (1)

National and state-level colorectal cancer mortality trends in Mexico, 1998-2018

Espinosa-Tamez P, Suazo-Zepeda E, Sánchez-Blas H, Meneses-Medina M, Huitzil-Meléndez FD, Van Loon K, Potter MB, Lajous M

Language: English
References: 38
Page: 5-13
PDF size: 438.27 Kb.


ABSTRACT

Objective. To describe the burden of colorectal cancer (CRC) in Mexico and understand mortality patterns based on sex, geography, and insurance status. Materials and methods. Mortality data (1998-2018) from the Instituto Nacional de Estadística y Geografía was obtained. We included colon (C18.0, C18.2-18.9) and rectal cancer ICD-10 codes (C19, C20), and estimated age-standardized national, statelevel and health insurance mortality rates. We estimated the average annual percent change using joinpoint regression. Results. Between 1998 and 2018, the observed women and men mortality rate increased annually by 1.3 and 2.7%, respectively. Higher CRC mortality was observed in northern and more urbanized states and in groups with greater access to health insurance, which currently facilitates but does not routinely cover screening. Conclusion. CRC mortality in Mexico is increasing rapidly, with marked differences based on sex, geography, and insurance status. Our findings underscore potential benefits of increased investment in comprehensive screening, diagnosis, and treatment strategies for the general population.


REFERENCES

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492

  2. International Agency for Research on Cancer. Global Cancer Observatory [Internet]. 2018 [cited November 29, 2020]. Available from: http:// gco.iarc.fr/

  3. Golan S, Eggener S. GLOBOCAN 2012 v 1.0, cancer incidence and mortality worldwide: IARC CancerBase. J Endourol. 2015;11(2):495-7. https://doi.org/10.1089/end.2015.1513

  4. IfHMaE (IHME). GBD Compare Data Visualization. Seattle: IHME, University of Washington, 2017 [cited November 29, 2020]. Available from: http://vizhub.healthdata.org/gbd-compare

  5. Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman- Retana O, Montero P, González-Robledo MC, et al. The burden of cancer in Mexico, 1990-2013. Salud Publica Mex. 2016;58(2):118-31. https://doi. org/10.21149/spm.v58i2.7780

  6. Gomez-Dantes H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, Darney B, Avila-Burgos L, et al. Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;388(10058):2386-402. https://doi. org/10.1016/s0140-6736(16)31773-1

  7. Reynoso-Noverón N, Meneses-García A, Erazo-Valle A, Ríos Escuderode los PE, Kuri-Morales PA, Mohar-Betancourt A. Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico. Salud Publica Mex. 2016;58(2):325-33. https:// doi.org/10.21149/spm.v58i2.7804

  8. Instituto Nacional de Estadística y Geografía. Panorama sociodemográfico de México 2015. Encuesta Intercensal (2015) [Internet]. Mexico: INEGI, 2015 [cited November 29, 2020]. Available from: http://seieg.iplaneg.net/ seieg/doc/Panorama_Sociodemografico_2015_1452886126.pdf

  9. Sánchez-Barriga JJ. Mortality trends and risk of dying from colorectal cancer in the seven socioeconomic regions of Mexico, 2000-2012. Rev Gastroenterol México. 2017;82(3):217-25. https://doi.org/10.1016/j. rgmxen.2017.03.010

  10. Roesch-Dietlen F, Ortuño-García KJ, González-Santés M, Grube-Pagola P, Remes-Troche JM, Díaz-Roesch F, et al. Cancer of the digestive system in Veracruz. The magnitude of the problem by 2025. Rev Gastroenterol Mex. 2020;85(2):145-50. https://doi.org/10.1016/j.rgmx.2019.03.008

  11. Borja-Aburto VH, Dávila-Torres J, Rascón-Pacheco RA, González- León M, Fernández-Gárate JE, Mejía-Rodríguez I, et al. Cancer mortality in the Mexican Social Security Institute, 1989-2013. Salud Publica Mex. 2016;58(2):153-61. https://doi.org/10.21149/spm.v58i2.7784

  12. Consejo Nacional de Población. Datos Abiertos de México - Proyecciones de la Población de México y de las Entidades Federativas, 2016-2050 [Internet]. Mexico: Conapo [cited November 29, 2020]. Available from: http://www.conapo.gob.mx/work/models/CONAPO/Datos_Abiertos/ Proyecciones2018/pob_mit_proyecciones.csv

  13. Instituto Nacional de Estadística y Geografía. XII Censo General de Población y Vivienda 2000.Tabulados de la muestra censal [Internet]. Mexico: INEGI, 2000 [cited November 29, 2020]. Available from: https:// www.inegi.org.mx/programas/ccpv/2000/#Tabulados

  14. Instituto Nacional de Estadística y Geografía. Censo de Población y Vivienda 2010 - Población total por entidad federativa, sexo y grupos quinquenales de edad según condición de derechohabiencia a servicios de salud y tipo de institución [Internet]. Mexico: INEGI [cited November 29, 2020]. Available from: https://inegi.org.mx/contenidos/programas/ ccpv/2010/tabulados/Basico/09_02B_ESTATAL.xls

  15. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2006. Mexico: INSP [cited November 29, 2020]. Available from: https://ensanut.insp.mx/encuestas/ensanut2006/descargas.php

  16. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2012. Mexico: INSP, 2012 [cited November 29, 2020]. Available from: https://ensanut.insp.mx/encuestas/ensanut2012/descargas.php

  17. Instituto Nacional de Estadística y Geografía. Encuesta Nacional de la Dinámica Demográfica. Porcentaje de población total en ámbito de localidad urbano. Mexico: INEGI/ENADID, 2014 [cited November 29, 2020]. Available from: https://www.inegi.org.mx/app/indicadores/?ind=620 0112373&tm=7#

  18. Fullman N, Yearwood J, Abay SM, Abbafati C, Abd-Allah F, Abdela J, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391(10136):2236-71. https://doi.org/10.1016/S0140-6736(18)30994-2

  19. Collaborators G 2016 HA and Q. Global Burden of Disease Study 2016 (GBD 2016) Healthcare Access and Quality Index Based on Amenable Mortality 1990–2016. GHDx [cited November 29, 2020]. Available from: http://ghdx.healthdata.org/record/ihme-data/gbd-2016-healthcareaccess- and-quality-index-1990-2016

  20. Ahmad OB, Boschi-pinto C, Lopez AD. Age standardization of rates: a new WHO standard. GPE Discuss Pap Ser. 2001;(31):1-14 [cited November 29, 2020]. Available from: https://www.who.int/healthinfo/ paper31.pdf

  21. Abbiss H, Abbott S, Armstrong M, Balkwill A, Benson V, Beral V, et al. Trends in mortality from major cancers in the Americas: 1980–2010. Ann Oncol. 2014;25:1843-53. https://doi.org/10.1093/annonc/mdu206

  22. Dutra VGP, Parreira VAG, Guimarães RM. Evolution of mortality for colorectal cancer in Brazil and regions, by sex, 1996-2015. Arq Gastroenterol. 2018;55(1):61-5. https://doi.org/10.1590/s0004- 2803.201800000-12

  23. Center MM, Jemal A, Smith RA, Ward E. Worldwide Variations in Colorectal Cancer. CA Cancer J Clin. 2009;59(6):366-78. https://doi. org/10.3322/caac.20038

  24. Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Sex- and genderspecific disparities in colorectal cancer risk. World J Gastroenterol. 2015;21(17):5167-75. https://doi.org/10.3748/wjg.v21.i17.5167

  25. Giacchetti S, Dugué PA, Innominato PF, Bjarnason GA, Focan C, Garufi C, et al. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: A meta-analysis. Ann Oncol. 2012;23(12):3110-6. https://doi.org/10.1093/annonc/mds148

  26. Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, Iacopetta B. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet. 2000;355(9217):1745-50. https://doi. org/10.1016/S0140-6736(00)02261-3

  27. Walker GV, Grant SR, Guadagnolo BA, Hoffman KE, Smith BD, Koshy M, et al. Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol. 2014;32(28):3118-5. https://doi.org/10.1200/JCO.2014.55.6258

  28. Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Trends in cancer survival by health insurance status in California from 1997 to 2014. JAMA Oncol. 2018;4(3):317-23. https://doi.org/10.1001/jamaoncol. 2017.3846

  29. Tawk R, Abner A, Ashford A, Brown CP. Differences in colorectal cancer outcomes by race and insurance. Int J Environ Res Public Health. 2015;13(1). https://doi.org/10.3390/ijerph13010048

  30. Instituto Nacional de Estadística y Geografía. Encuesta Intercensal 2015 - Estimadores de la población total y su distribución porcentual según condición de afiliación a servicios de salud e institución por tamaño de localidad, sexo y grupos quinquenales de edad [Internet]. Mexico: INEGI, 2016 [cited November 29, 2020]. Available from: https://www. inegi.org.mx/contenidos/programas/intercensal/2015/tabulados/07_servicios_ de_salud.xls

  31. Wen D, Zou W, Wen X, Yang Y, Chen Y, He Y, et al. Urban-rural disparity in colorectal cancer incidence and increasing trend in relation to socioeconomic development and urbanization in China. J Int Med Res. 2018. https://doi.org/10.1177/0300060518791090

  32. Song HN, Go S Il, Lee WS, Kim Y, Choi HJ, Lee US, et al. Populationbased regional cancer incidence in Korea: Comparison between urban and rural areas. Cancer Res Treat.2016;48(2):789-97. https://doi.org/10.4143/ crt.2015.062

  33. Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004;13(2):127-32. https://doi.org/10.1097/00008469-200404000-00006

  34. Pérez-Tepayo S, Rodríguez-Ramírez S, Unar-Munguía M, Shamah-Levy T. Trends in the dietary patterns of Mexican adults by sociodemographic characteristics. Nutr J. 2020;19(1). https://doi.org/10.1186/s12937-020- 00568-2

  35. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: An assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171-7. Available from: https://apps.who.int/iris/handle/10665/72966

  36. Lozano-Esparza S, Stern D, Hernández-Ávila JE, Morales-Carmona E, Mohar A, Lajous M. Evaluating Mexico’s low cancer mortality using two national death registries. Salud Publica Mex. 2020;62(2):181-5. https://doi. org/10.21149/10635

  37. Bautista-Arredondo S, Servan-Mori E, Colchero MA, Ramirez-Rodriguez B, Sosa-Rubi SG. Analysis of outpatient healthcare utilization in the context of the universal healthcare coverage reform in Mexico. Salud Publica Mex. 2014;56(1):18-31. https://doi.org/10.21149/spm.v56i1.7319

  38. Instituto Mexicano del Seguro Social. Metodología de cálculo de la cifra de población derechohabiente adscrita a Unidades de Medicina Familiar del Instituto Mexicano del Seguro Social. Mexico: IMSS, 2020 [cited November 29, 2020]. Available from: http://datos.imss.gob.mx/sites/ default/files/metodologia_pda_0.pdf




2020     |     www.medigraphic.com